NVMDF News and Press, Novamind Inc. From 04/19/21

LOS ANGELES, CA / ACCESSWIRE / April 19, 2021 / The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The Planet MicroCap Showcase: VIRTU...

Psychedelic Penny Stocks Continue Gaining Ground Among Mainstream Investors Like any “fringe industry,” there’s plenty of hype and speculation driving momentum behind penny stocks in certain industries. Those of you who’ve been in the markets for the last few...

Panel discussion on psychedelic treatments and therapies to feature Novamind's Chief Medical Officer TORONTO, ON / ACCESSWIRE / March 22, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic me...

Novamind's subsidiary, Cedar Clinical Research, to serve as a key clinical research site TORONTO, ON / ACCESSWIRE / March 18, 2021 / Novamind Inc., (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pl...

Joseph Braganza joins the organization as SVP, Head of M&A Previously led M&A at Canadian Addiction Treatment Centres (CATC) TORONTO, ON / ACCESSWIRE / March 3 , 2021 / Novamind Inc., (CSE:NM)(OTC PINK:NVMDF) ("Novamind" or the "Company"), a leading mental health compa...

Psychedelic medicine company Novamind Inc. (OTC:NVMDF) reported its fiscal second-quarter results for the three months ended December 31, 2020. Novamind reported revenue of $1,288,828 primarily composed of patient services revenue from its network of four Cedar Psychiatry outp...

NOVAMIND INC (NVMDF): FQ2 GAAP EPS of -$0.11.Revenue of $1.29MPress Release For further details see: NOVAMIND INC reports FQ2 results

$1.29 million in fiscal second quarter revenue Clinics see continued surge in demand for mental health services Ongoing expansion of clinic capacity TORONTO, ON / ACCESSWIRE / March 1, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF) ("Novamind" or "the Company"), a leading menta...

Psychedelics panel discussion to feature Novamind's Chief Medical Officer Toronto, Ontario--(Newsfile Corp. - February 24, 2021) - Novamind Inc. (CSE: NM) (OTC Pink: NVMDF) ("Novamind" or "the Company"), a leading mental health company specialized in psychedelic medicine, is pleased to anno...